Olmesartan medoxomil is associated with decreased plasma AGEs, pentosidine, and N-(epsilon)-carboxymethyl-lysine levels in hemodialysis patients (Q82845592)
Jump to navigation
Jump to search
scientific article published on 09 December 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Olmesartan medoxomil is associated with decreased plasma AGEs, pentosidine, and N-(epsilon)-carboxymethyl-lysine levels in hemodialysis patients |
scientific article published on 09 December 2011 |
Statements
Olmesartan medoxomil is associated with decreased plasma AGEs, pentosidine, and N-(epsilon)-carboxymethyl-lysine levels in hemodialysis patients (English)
Hirokazu Honda
Nozomu Hosaka
Yumie Aoshima
Yuki Hirai
Tetsuo Michihata
Tadao Akizawa
9 December 2011